Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01992757 · ClinicalTrials.gov registry record

Thromboelastography-derived Functional Fibrinogen Levels

A clinical trial of Focus of Study and Coagulation Status of Cardiac Surgery Patient, sponsored by University of Pennsylvania.

Completed
Registry status
51
Enrollment target
1
Study location

NCT01992757 is a study of Focus of Study and Coagulation Status of Cardiac Surgery Patient that has completed, run by University of Pennsylvania. The registered enrollment target is 51 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01992757, a study of Focus of Study and Coagulation Status of Cardiac Surgery Patient, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
51 participants
Enrollment target
1
Study location

Study Summary

This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirements

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2013-11
Est. Completion 2015-08

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01992757

The ClinicalTrials.gov registry entry for NCT01992757 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Focus of Study appearing as the primary indexed condition, and to 0 interventions.

NCT01992757 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01992757 about?

NCT01992757 is a clinical study titled "Thromboelastography-derived Functional Fibrinogen Levels". This study hopes to determine if thromboelastography-derived functional fibrinogen (TEG-FF or FLEV) levels obtained during the rewarming phase of cardiopulmonary bypass can provide information on coagulation status sooner, allowing for anticipation of post-bypass bleeding and transfusion requirement...

What is the current status of trial NCT01992757?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2013-11. Estimated completion is 2015-08.

What conditions does trial NCT01992757 study?

This clinical trial studies the following conditions: Focus of Study, Coagulation Status of Cardiac Surgery Patient, Reducing Excess Blood Transfusion.

Who is sponsoring clinical trial NCT01992757?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01992757 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.